-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Twist Bioscience, Raises Price Target to $215

Benzinga·10/07/2026 15:35:03
Barclays analyst Luke Sergott maintains Twist Bioscience (NASDAQ:TWST) with a Overweight and raises the price target from $112 to $215.